You are here

Luye Pharma Group

Luye submits NDA for schizophrenia, bipolar disorder therapy

BioCentury

Sat, 03/30/19 - 01:02 pm

Luye Pharma Group

bipolar disorder

Luye Pharma Buys Rights to Seroquel in China and Other Territories for $538 Million

CP Wire

Mon, 05/7/18 - 05:26 pm

Luye Pharma Group

Luye Pharma Buys Rights to Seroquel in China and Other Territories for $538 Million

Mon, 05/7/18 - 05:22 pm

Luye Pharma Group

China Biotech Week In Review: Regeneron Pharma, Bayer Start New Trial For DME Treatment

Seeking Alpha

Sun, 02/24/13 - 02:34 pm

Golong Medicine

Reckitt Benckiser

Luye Pharma Group

Double-Crane Pharma